Anemia Is a Novel Predictive Factor for the Onset of Severe Chemotherapy-Induced Peripheral Neuropathy in Lymphoma Patients Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisolone Therapy
Keywords: Anemia; Chemotherapy-induced peripheral neuropathy (CIPN); Diffuse large B-cell lymphoma (DLBCL); R-CHOP
Document Type: Research Article
Affiliations: 1: Department of Community Health Sciences, Kobe University Graduate School of Health Sciences, Kobe, Japan 2: Department of Medical Oncology and Hematology, Kakogawa Central City Hospital, Kakogawa, Japan 3: Division of Rehabilitation Medicine, Kobe University Hospital, Kobe, Japan 4: Division of Nursing, Kobe University Hospital, Kobe, Japan 5: Division of Medical Oncology and Hematology, Kobe University, Kobe, Japan
Publication date: 29 March 2019
Formerly: Oncology Research Incorporating Anti-Cancer Drug Design
Oncology Research Featuring Preclinical and Clincal Cancer Therapeutics publishes research of the highest quality that contributes to an understanding of cancer in areas of molecular biology, cell biology, biochemistry, biophysics, genetics, biology, endocrinology, and immunology, as well as studies on the mechanism of action of carcinogens and therapeutic agents, reports dealing with cancer prevention and epidemiology, and clinical trials delineating effective new therapeutic regimens.From Volume 23, Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics is Open Access under the terms of the Creative Commons CC BY-NC-ND license.
- Editorial Board
- Information for Authors
- Submit a Paper
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content